Reusable Gastroenterology Endoscope Market Global Report 2026

The reusable gastroenterology endoscope market size has grown rapidly in recent years. It will grow from $13.27 billion in 2025 to $14.76 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to rising prevalence of gastrointestinal disorders, increasing volume of endoscopic diagnostic procedures, expansion of hospital endoscopy departments, growing awareness of early disease detection, increasing adoption of minimally invasive treatment approaches.

The reusable gastroenterology endoscope market size is expected to see rapid growth in the next few years. It will grow to $22.21 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to advancements in endoscope imaging technologies, growing demand for therapeutic gastrointestinal interventions, increasing healthcare expenditure on endoscopic equipment, expansion of ambulatory surgical center services, rising focus on infection prevention and reprocessing standards. Major trends in the forecast period include growing adoption of high definition imaging endoscopes, rising demand for minimally invasive gastrointestinal procedures, increasing preference for reusable endoscopes with enhanced sterilization compatibility, expansion of therapeutic endoscopy procedures across healthcare facilities, growing utilization of ultra slim endoscopes for improved patient comfort.

The growing prevalence of gastrointestinal disorders is anticipated to drive the growth of the reusable gastroenterology endoscope market in the coming years. Gastrointestinal disorders are health conditions that impact the digestive system, including the esophagus, stomach, intestines, colon, rectum, liver, pancreas, and related organs, and often require diagnostic and therapeutic procedures. The increasing prevalence of gastrointestinal disorders is attributed to the rising occurrence of colorectal cancer and chronic digestive conditions associated with aging populations. Reusable gastroenterology endoscopes aid in the management of gastrointestinal disorders by facilitating precise diagnosis, regular screening, biopsy collection, lesion removal, and minimally invasive therapeutic procedures in high-volume healthcare environments. For example, in January 2024, according to the American Cancer Society, a US-based nonprofit cancer organization, colorectal cancer (CRC) was the second leading cause of cancer-related deaths in the United States, with around 53,010 deaths expected in 2024, slightly above the estimated 52,550 deaths recorded in the previous year. Therefore, the rising prevalence of gastrointestinal disorders is contributing to the expansion of the reusable gastroenterology endoscope market.

The growing demand for minimally invasive procedures is expected to drive the growth of the reusable gastroenterology endoscope market in the forecast period. Minimally invasive procedures are medical treatments performed through small incisions or natural body openings using specialized instruments and imaging technologies to minimize tissue damage, discomfort, and recovery duration compared to conventional surgical methods. The adoption of minimally invasive procedures is increasing due to their benefits, including shorter recovery periods, quicker patient return to daily activities, reduced hospital stays, and lower overall healthcare resource utilization. Reusable gastroenterology endoscopes facilitate minimally invasive procedures by providing clear visualization of the gastrointestinal tract, allowing accurate diagnosis and treatment through natural openings without requiring extensive surgical incisions. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based organization representing board-certified plastic surgeons, minimally invasive procedures grew by 7% in 2023, surpassing the 2% growth observed in surgical procedures. Therefore, the rising demand for minimally invasive procedures is fueling the growth of the reusable gastroenterology endoscope market.

Major companies operating in the reusable gastroenterology endoscope market are focusing on developing advanced endoscopes to enhance visualization capabilities, improve lesion detection accuracy, and increase procedural efficiency in gastrointestinal diagnostic and therapeutic procedures. Advanced endoscopes are technologically advanced endoscopic devices that integrate features such as high-definition imaging, image-enhancement technologies, magnification, artificial intelligence, and therapeutic functionalities to support improved detection, diagnosis, and treatment of diseases affecting internal organs and body cavities. For example, in October 2023, Olympus Corporation, a Japan-based medical technology company, launched the EVIS X1 endoscopy system with the GIF-1100 gastrointestinal videoscope series. The system incorporates Extended Depth of Field (EDOF) technology for enhanced image clarity, Texture and Color Enhancement Imaging (TXI) for improved mucosal visualization, and Red Dichromatic Imaging (RDI) technology to enhance the visibility of deep blood vessels and bleeding points during gastrointestinal procedures.

Major companies operating in the reusable gastroenterology endoscope market report are Fujifilm Holdings Corporation, Olympus Corporation, HOYA Corporation, KARL STORZ SE & Co. KG, Richard Wolf GmbH, SonoScape Medical Corp., XION GmbH, Shanghai Aohua Photoelectric Endoscope Co. Ltd., Huger Medical Instrument Co. Ltd.

North America was the dominating region in the reusable gastroenterology endoscope market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the reusable gastroenterology endoscope market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the reusable gastroenterology endoscope market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.